Revive Therapeutics Ltd (RVVTF)
0.017
0.00 (0.00%)
USD |
OTCM |
Jun 03, 15:18
Revive Therapeutics Price to Book Value: 0.8482 for June 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 0.8282 |
| May 30, 2024 | 0.8781 |
| May 29, 2024 | 0.888 |
| May 28, 2024 | 0.9978 |
| May 24, 2024 | 1.023 |
| May 23, 2024 | 1.008 |
| May 22, 2024 | 0.9354 |
| May 21, 2024 | 0.923 |
| May 20, 2024 | 0.8481 |
| May 17, 2024 | 0.9978 |
| May 16, 2024 | 0.9953 |
| May 15, 2024 | 0.9728 |
| May 14, 2024 | 1.043 |
| May 13, 2024 | 1.023 |
| May 10, 2024 | 0.9978 |
| May 09, 2024 | 0.9479 |
| May 08, 2024 | 1.005 |
| May 07, 2024 | 1.005 |
| May 06, 2024 | 0.9928 |
| May 03, 2024 | 0.9978 |
| May 02, 2024 | 0.9479 |
| May 01, 2024 | 1.018 |
| April 30, 2024 | 1.068 |
| April 29, 2024 | 1.010 |
| April 26, 2024 | 1.048 |
| Date | Value |
|---|---|
| April 25, 2024 | 1.025 |
| April 24, 2024 | 1.073 |
| April 23, 2024 | 1.003 |
| April 22, 2024 | 1.055 |
| April 19, 2024 | 0.9978 |
| April 18, 2024 | 0.9978 |
| April 17, 2024 | 1.028 |
| April 16, 2024 | 1.003 |
| April 15, 2024 | 1.026 |
| April 12, 2024 | 0.9978 |
| April 11, 2024 | 1.055 |
| April 10, 2024 | 1.063 |
| April 09, 2024 | 1.128 |
| April 08, 2024 | 1.118 |
| April 05, 2024 | 0.9978 |
| April 04, 2024 | 1.073 |
| April 03, 2024 | 1.073 |
| April 02, 2024 | 1.148 |
| April 01, 2024 | 1.088 |
| March 28, 2024 | 1.053 |
| March 27, 2024 | 1.122 |
| March 26, 2024 | 1.050 |
| March 25, 2024 | 1.084 |
| March 22, 2024 | 1.098 |
| March 21, 2024 | 1.023 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8282
Minimum
May 31 2024
20.64
Maximum
Dec 14 2020
5.585
Average
5.098
Median
Apr 05 2021
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4084 |
| Aurinia Pharmaceuticals Inc | 2.026 |
| Edesa Biotech Inc | 3.354 |
| Lexaria Bioscience Corp | 7.648 |
| Xenon Pharmaceuticals Inc | 3.268 |
Price to Book Value Related Metrics
| Price | 0.017 |
| Earnings Yield | -79.47% |
| Market Cap | 6.094M |